Augmentation of facial defects remains an area of challenge and controversy. Advocates of alloplastic implants cite the convenience of prepackaged materials, which they feel outweighs the possibility of rejection. Those favoring autografts prefer their long-term predictability, but must contend with resorption and the disadvantages of obtaining the implantation material. The use of supramid mesh may combine the advantages of allopasts with the long-term predictability of autografts after fibrous ingrowth has occurred. Our experience over the past 4 years in 164 cases indicates that supramide mesh may represent a significant advance in augmentation of facial deformities.